Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Name: Jamie D. Feusner - Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
SKU: pb-42-1-feusner
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

SKU: pb-42-1-feusner Categories: Psychopharmacology Bulletin, VOL 42 No. 1 Articles Tags: alexander-bystritsky, generalized-anxiety-disorder, glutamate, jamie-d-feusner, lauren-kerwin, medworks-media, memantine, nmda-receptor, no-1, obsessive-compulsive-disorder, psychopharmacology-bulletin, sanjaya-saxena, volume-42

Description

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

MWM-PSB-42-01-2009-FEUSNER

Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

Zonisamide for Bipolar Depression by Deborah Dauphinais

Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

Related products

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

Zonisamide for Bipolar Depression by Deborah Dauphinais